<bill session="113" type="h" number="5750" updated="2014-12-06T07:10:56-05:00">
  <state datetime="2014-11-20">REFERRED</state>
  <status>
    <introduced datetime="2014-11-20"/>
  </status>
  <introduced datetime="2014-11-20"/>
  <titles>
    <title type="short" as="introduced">Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.</title>
  </titles>
  <sponsor id="412250"/>
  <cosponsors>
    <cosponsor id="400616" joined="2014-11-20"/>
    <cosponsor id="400170" joined="2014-11-20"/>
    <cosponsor id="400654" joined="2014-11-20"/>
  </cosponsors>
  <actions>
    <action datetime="2014-11-20" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Administrative remedies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government information and archives"/>
    <term name="Intellectual property"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
</bill>
